z-logo
Premium
In vivo Antiviral Activity of Stephania cepharantha against Herpes Simplex Virus Type‐1
Author(s) -
Nawawi As'ari,
Nakamura Norio,
Meselhy Meselhy R.,
Hattori Masao,
Kurokawa Masahiko,
Shiraki Kimiyasu,
Kashiwaba Noriaki,
Ono Minoru
Publication year - 2001
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.881
Subject(s) - alkaloid , in vivo , lesion , herpes simplex virus , pharmacology , traditional medicine , body weight , medicine , chemistry , virus , biology , virology , stereochemistry , pathology , microbiology and biotechnology
The antiviral activity of a MeOH extract of Stephania cepharantha (root tubers), its CHCl 3 ‐soluble fraction (alkaloid fraction) and the major alkaloid FK‐3000 ( 1 ) were investigated in BALB/c mice cutaneously infected with HSV‐1 strain 7401H. At doses of 125 and 250 mg/kg body weight, p.o., the MeOH extract significantly delayed skin lesion on score 2 (vesicles in the local region), limited the development of further lesions on score 6 (mild zosteriform lesion) and prolonged the mean survival time of HSV‐1 infected mice. After p.o. administration of the CHCl 3 ‐soluble fraction at doses of 25 and 50 mg/kg or FK‐3000 ( 1 ) at 10 and 25 mg/kg, similar results were obtained. Although the alkaloid improved the survival of infected mice, it had a narrow therapeutic index. Copyright © 2001 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom